An FDA pivotal trial of our hospital monitoring device is underway at multiple sites, following promising first-in-human pilot studies and foundational research.
Clinical Evidence for Sense Technology
9 patients enrolled
600 hours of monitoring time
3600 SENSE scans performed
7 no expansion
100% correspondence of SENSE with CT results at 12 hours. No false positives/no false negatives.
5 LVO*, 5 non LVO*, 5 ICH**
Study conducted at Good Samaritan Hospital and UC
5 non-LVO* completed
5 ICH** completed
**Intracerebral hemorrhage (ICH)
Case Study: Hospital Monitoring
We are driven by our mission and are committed to impacting people’s lives and enhancing neurological health globally. You can be part of our journey too.